Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Results and Performance
ABT logo

Abbott Laboratories Achieves 7.5% Organic Growth and Completes Landmark Exact Sciences Acquisition

ABT10-QFiling Date: 4/29/2026
Abbott Laboratories
Description

What this story covers

Abbott Laboratories reported $10.6 billion in quarterly sales, driven by 7.5% organic growth. The company strengthened its diagnostic portfolio by acquiring Exact Sciences and maintained a $7 billion repurchase authorization, signaling strong financial health and strategic expansion into oncology.

Story snapshot

CompanyAbbott Laboratories
TickerABT
VariantStandard detailed
Duration13:18
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-028357
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in